PONS ^Company

PONS bridges the upstream–downstream imaging gap with patented image enhancement that exposes subtle early-stage tissue shapes and malignant-risk patterns previously invisible to clinicians, and with an AI system for tissue characterization that amplifies ultrasound data size by 50× and optimizes AI systems for diagnostic accuracy. By transforming a single scan into high-resolution, AI-ready insight, PONS enables mass-market, precision ultrasound and accelerates the shift toward decentralized, proactive healthcare.
Making ultrasound accessible to the mass market by addressing the limitations of high-resolution images in the early stages of disease.